Not finding it? Sign in to also search OpenAlex live.
-
Inoculum cell count influences separation efficiency and variance in Ames plate incorporation and Ames RAMOS test2023 The Science of The Total Environment article Biochemistry, Genetics and Molecular Biology Carcinogens and Genotoxicity Assessment Open access
Eva Forsten, Maurice Finger, Theresa Scholand, Alexander Deitert, Kira Kauffmann, Jochen Büchs
2citations -
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial2022 Journal of Clinical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans A. J. Gelderblom, Suzanne George, Patrick Schöffski, +13 more
121citations -
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial2021 Nature Medicine article Immunology and Microbiology Mast cells and histamine Open access cited by 1 patent
Jason R. Gotlib, Andreas Reiter, Deepti H. Radia, Michael W. Deininger, Tracy I. George, Jens Panse, +18 more
151citations -
Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms2024 Frontiers in Immunology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Tobias Idor Boklund, Johanne Gudmand‐Hoeyer, Morten Kranker Larsen, Trine Alma Knudsen, Christina Schjellerup Eickhardt‐Dalbøge, Vibe Skov, +5 more
8citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy
Liesbeth M. Hondelink, Sophie M. Ernst, Peggy N. Atmodimedjo, Danielle B. Cohen, Janina L Wolf, Anne‐Marie C. Dingemans, +2 more
33citations -
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study2021 JNCI Journal of the National Cancer Institute article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Marthe M. de Jonge, Cor Doede de Kroon, Denise J. Jenner, Jan Oosting, Joanne A. de Hullu, Marian J.E. Mourits, +12 more
94citations -
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study
Desireé Kunadt, Sven Zukunft, Christoph Röllig, Stephan Metzelder, Andreas Burchert, Eva Wagner‐Drouet, +50 more
0citations